Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RSCF | US
0.00
6.15%
Healthcare
Medical Instruments & Supplies
30/06/2024
21/10/2024
0.05
0.06
0.06
0.05
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
102.3%1 month
133.3%3 months
123.2%6 months
133.6%-
-
2.32
-
-
-11.73
2.13
-
831.59K
4.55M
4.55M
-
16.67
-54.80
374.40
-2.69
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.01
Range1M
0.01
Range3M
0.02
Rel. volume
0.42
Price X volume
270.50
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6642 | 4.43M | -1.91% | n/a | 65.94% |
| NUWE | NUWE | Medical Devices | 1.95 | 3.64M | 31.76% | n/a | -9.57% |
| Sonendo Inc. | SONX | Medical Devices | 0.0492 | 3.58M | -1.60% | n/a | 0.00% |
| Common Stock | VERO | Medical Devices | 0.4633 | 3.36M | -3.28% | n/a | 1351.51% |
| INVO Bioscience Inc | INVO | Medical Devices | 0.833 | 3.25M | -2.91% | 1.24 | 394.32% |
| Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.69 | 2.81M | -8.65% | n/a | 38.66% |
| Sintx Technologies Inc | SINT | Medical Devices | 3.27 | 2.44M | 0.62% | n/a | 47.07% |
| Tenon Medical Inc | TNON | Medical Devices | 4.12 | 2.33M | -0.48% | n/a | 67.43% |
| Helius Medical Technologies Inc | HSDT | Medical Devices | 0.57 | 2.04M | 5.56% | n/a | 0.55% |
| Avinger Inc | AVGR | Medical Devices | 0.913 | 1.99M | -3.89% | n/a | 74.23% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -11.73 | - | Cheaper |
| Ent. to Revenue | 2.13 | - | Cheaper |
| PE Ratio | - | 47.18 | - |
| Price to Book | 2.32 | 5.71 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 123.20 | - | Riskier |
| Debt to Equity | - | 0.92 | - |
| Debt to Assets | - | 0.27 | - |
| Market Cap | 4.55M | - | Emerging |